Frances Slater

Frances Slater

Frances Slater, PhD, is a Senior Technical and Marketing Writer for Global MDx Marketing at QIAGEN. She trained as a molecular biologist at King's College London before moving into marketing communications for the pharmaceutical and diagnostics industries. She is passionate about communicating the power and value of molecular technologies for research and healthcare.

QIAGEN partners to develop predictive tests in oncology

Yesterday, we announced that QIAGEN was entering into a licensing and co-development agreement with Therawis Diagnostics GmbH to develop and commercialize predictive assays in oncology. An initial project will be to develop and market PITX2 as a marker to predict effectiveness of anthracycline treatment in triple negative and other high-risk breast cancer patients. See the full press release… Read article →


Infographic: Filtering the flood

The global DNA sequencing capacity is increasing 3x-5x per year, leading to an unprecedented flood of biological data. Already, the output of biological data amounts to 15 petabytes a year (the equivalent of >3 million DVDs) and its amount doubles every 9 months, making it hard for scientists to keep up and put the information… Read article →